Not investment advice. Educational platform. See Disclaimer.
NYSE: RVTY
Revvity, Inc.
Healthcare | Medical - Diagnostics & Research
$130.22-0.41 (-0.31%)as of 2026-09-04 21:54 UTC
Market Cap$14.5B
Volume1.17M
EPS (TTM)$2.07
Revvity, Inc. (NYSE: RVTY) is a $14.5B medical - diagnostics & research company trading at $130.22 (−0.3% today) — 62.9× trailing earnings, yielding 0.22%. Figures from SEC EDGAR and market feeds; updated 2026-09-04 21:54 UTC.
52-Week Range
Low $81.22High $133.00
What Revvity, Inc. does
Revvity is a health science company headquartered in Waltham, Massachusetts that provides technologies, expertise and services supporting scientific research and medical applications from discovery through diagnosis and treatment. The company operates in two business segments—Life Sciences and Diagnostics—and serves pharmaceutical, biotech, contract research, academic and government institutions globally.
Revvity is a health science company headquartered in Waltham, Massachusetts that provides technologies, expertise and services supporting scientific research and medical applications from discovery through diagnosis and treatment.
What is RVTY's valuation?
RVTY trades at $130.22, 62.91× trailing earnings, 22.10× EV/EBITDA, as of 2026-09-04. It carries a 0.22% dividend yield.
When did RVTY last file with the SEC?
Revvity, Inc.'s most recent SEC filing on record is a 10-Q filed 2026-05-12. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings and public market data feeds, fetched 2026-09-04 21:54 UTC. This page is also available as JSON at /api/data?ticker=RVTY and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for RVTY and 5,000+ tickers.
